Exozymes EXOZ
NASDAQ EXOZ
$5.83 -0.01 (-0.17%)
At close: Sep 30, 2026 · 4:00 PM EDT

Exozymes (EXOZ) Non-Current Deffered Revenue (2023 - 2026)

Updated

Exozymes (EXOZ) recorded Non-Current Deffered Revenue of $66,382 in Q2 2026, down 42.8% from $116,119 a year earlier.

Analysis

Exozymes (EXOZ) Non-Current Deffered Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025, Exozymes reported Non-Current Deffered Revenue of $90,365, down 26.9% from FY2024.

  • Across earlier years, Non-Current Deffered Revenue came in at $123,579 in FY2024 (-12.2%) and $140,703 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Linde 218.80 Bn 201.92 Bn 4.43 Bn -
2 Corning 132.43 Bn 125.56 Bn 1.63 Bn -
3 Sherwin Williams 78.49 Bn 77.53 Bn 3.34 Bn -
4 Air Products & Chemicals 61.97 Bn 59.87 Bn 1.04 Bn -
5 Corteva 51.82 Bn 40.62 Bn 3.66 Bn -
6 LyondellBasell Industries 37.12 Bn 26.74 Bn 2.04 Bn -
7 Nutrien 33.86 Bn 30.73 Bn 3.25 Bn -
8 Qnity Electronics 26.31 Bn 23.73 Bn 666.00 Mn -
9 Ati 25.78 Bn 23.93 Bn 309.80 Mn -
10 Exozymes 54.11 Mn 54.11 Mn - 66,382.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66,382.00
Dec 31, 2025 90,365.00
Sep 30, 2025 103,065.00
Jun 30, 2025 116,119.00
Mar 31, 2025 110,123.00
Dec 31, 2024 123,579.00
Sep 30, 2024 137,035.00
Dec 31, 2023 140,703.00
API Access

Exozymes Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EXOZ&period=max&api_key=YOUR_API_KEY